Cardiovascular drug development: protocol design and methodology
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
New York [u.a.]
Dekker
1999
|
| Schriftenreihe: | Fundamental and clinical cardiology
35 |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | XIV, 232 S. |
| ISBN: | 0824719271 |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV012307249 | ||
| 003 | DE-604 | ||
| 005 | 19990201 | ||
| 007 | t | ||
| 008 | 981208s1999 |||| 00||| eng d | ||
| 020 | |a 0824719271 |9 0-8247-1927-1 | ||
| 035 | |a (OCoLC)39982766 | ||
| 035 | |a (DE-599)BVBBV012307249 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 050 | 0 | |a RM345 | |
| 082 | 0 | |a 615/.71 |2 21 | |
| 084 | |a XI 4305 |0 (DE-625)153005:12911 |2 rvk | ||
| 245 | 1 | 0 | |a Cardiovascular drug development |b protocol design and methodology |c ed. by Jeffrey S. Borer ... |
| 264 | 1 | |a New York [u.a.] |b Dekker |c 1999 | |
| 300 | |a XIV, 232 S. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Fundamental and clinical cardiology |v 35 | |
| 650 | 4 | |a Cardiovascular Agents |v Congresses | |
| 650 | 4 | |a Cardiovascular agents |x Research |x Methodology |v Congresses | |
| 650 | 4 | |a Clinical Trials as Topic |v Congresses | |
| 650 | 4 | |a Drug Approval |v Congresses | |
| 650 | 0 | 7 | |a Kreislaufmittel |0 (DE-588)4163325-8 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1996 |z Washington DC |2 gnd-content | |
| 689 | 0 | 0 | |a Kreislaufmittel |0 (DE-588)4163325-8 |D s |
| 689 | 0 | 1 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Borer, Jeffrey S. |e Sonstige |4 oth | |
| 830 | 0 | |a Fundamental and clinical cardiology |v 35 |w (DE-604)BV004737761 |9 35 | |
| 856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008342771&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-008342771 | ||
Datensatz im Suchindex
| _version_ | 1804126930717376512 |
|---|---|
| adam_text | Contents
Series Introduction (Samuel Z. Goldhaber) v
Preface vii
Contributors xiii
1. Drug Discovery and Development 1
John C. Somberg
I. Development of Congestive Heart Failure Therapy
2. Background Therapy in Congestive Heart Failure Studies 49
Jeffrey S. Borer
3. Congestive Heart Failure Trial Design 57
Raymond John Lipicky
4. Angiotensin Converting Enzyme Inhibitors for Mortality
Reduction in Congestive Heart Failure: Should Approval
Be Granted for a Class Effect? 63
Jeffrey S. Borer and John C. Somberg
5. Sudden Death in Congestive Heart Failure Trials 71
John C. Somberg
6. Panel Discussion 75
Jeffrey S. Borer, Moderator
II. Development of Antihypertensive Therapy
7. Antihypertensive Clinical Trials 101
Raymond John Lipicky
xi
xii Contents
8. Calcium Channel Blockers: Safety Issues 107
Jeffrey S. Borer
9. Panel Discussion 121
Jeffrey S. Borer, Moderator
III. Development of Antiarrhythmic Drug Therapy
10. Antiarrhythmics: Indications, Claims, and Trial Design 137
Raymond John Lipicky
11. Supraventricular Tachycardia Drugs and Trial Design
Issues 141
Robert Fenichel
12. Antiarrhythmic Trials: Update 145
John C. Somberg
13. Inter Ethnic Differences in the Susceptibility to Drug
Induced QT Interval Prolongation and Torsade de Pointes 151
Satish Singh
14. Panel Discussion 159
John C. Somberg, Moderator
IV. Development of Antilipid and Anti Ischemic Therapy
15. Antilipid Trial Endpoints 177
David Orloff
16. Natural History Endpoints and Angina Trials 185
Raymond John Lipicky
17. Development of Antiplatelet Drugs 189
Stephen Fredd
18. Panel Discussion 197
Jeffrey S. Borer, Moderator
V. Conclusion
19. Future Directions of Cardiovascular Drug Development 213
Jeffrey S. Borer
Index 223
|
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV012307249 |
| callnumber-first | R - Medicine |
| callnumber-label | RM345 |
| callnumber-raw | RM345 |
| callnumber-search | RM345 |
| callnumber-sort | RM 3345 |
| callnumber-subject | RM - Therapeutics and Pharmacology |
| classification_rvk | XI 4305 |
| ctrlnum | (OCoLC)39982766 (DE-599)BVBBV012307249 |
| dewey-full | 615/.71 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615/.71 |
| dewey-search | 615/.71 |
| dewey-sort | 3615 271 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01801nam a2200445 cb4500</leader><controlfield tag="001">BV012307249</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">19990201 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">981208s1999 |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0824719271</subfield><subfield code="9">0-8247-1927-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)39982766</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV012307249</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM345</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.71</subfield><subfield code="2">21</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 4305</subfield><subfield code="0">(DE-625)153005:12911</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Cardiovascular drug development</subfield><subfield code="b">protocol design and methodology</subfield><subfield code="c">ed. by Jeffrey S. Borer ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York [u.a.]</subfield><subfield code="b">Dekker</subfield><subfield code="c">1999</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XIV, 232 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Fundamental and clinical cardiology</subfield><subfield code="v">35</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiovascular Agents</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiovascular agents</subfield><subfield code="x">Research</subfield><subfield code="x">Methodology</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Clinical Trials as Topic</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Approval</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Kreislaufmittel</subfield><subfield code="0">(DE-588)4163325-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1996</subfield><subfield code="z">Washington DC</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Kreislaufmittel</subfield><subfield code="0">(DE-588)4163325-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Borer, Jeffrey S.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Fundamental and clinical cardiology</subfield><subfield code="v">35</subfield><subfield code="w">(DE-604)BV004737761</subfield><subfield code="9">35</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008342771&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-008342771</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 1996 Washington DC gnd-content |
| genre_facet | Konferenzschrift 1996 Washington DC |
| id | DE-604.BV012307249 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-09T18:25:17Z |
| institution | BVB |
| isbn | 0824719271 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-008342771 |
| oclc_num | 39982766 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | XIV, 232 S. |
| publishDate | 1999 |
| publishDateSearch | 1999 |
| publishDateSort | 1999 |
| publisher | Dekker |
| record_format | marc |
| series | Fundamental and clinical cardiology |
| series2 | Fundamental and clinical cardiology |
| spelling | Cardiovascular drug development protocol design and methodology ed. by Jeffrey S. Borer ... New York [u.a.] Dekker 1999 XIV, 232 S. txt rdacontent n rdamedia nc rdacarrier Fundamental and clinical cardiology 35 Cardiovascular Agents Congresses Cardiovascular agents Research Methodology Congresses Clinical Trials as Topic Congresses Drug Approval Congresses Kreislaufmittel (DE-588)4163325-8 gnd rswk-swf Arzneimittelentwicklung (DE-588)4143176-5 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1996 Washington DC gnd-content Kreislaufmittel (DE-588)4163325-8 s Arzneimittelentwicklung (DE-588)4143176-5 s DE-604 Borer, Jeffrey S. Sonstige oth Fundamental and clinical cardiology 35 (DE-604)BV004737761 35 HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008342771&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Cardiovascular drug development protocol design and methodology Fundamental and clinical cardiology Cardiovascular Agents Congresses Cardiovascular agents Research Methodology Congresses Clinical Trials as Topic Congresses Drug Approval Congresses Kreislaufmittel (DE-588)4163325-8 gnd Arzneimittelentwicklung (DE-588)4143176-5 gnd |
| subject_GND | (DE-588)4163325-8 (DE-588)4143176-5 (DE-588)1071861417 |
| title | Cardiovascular drug development protocol design and methodology |
| title_auth | Cardiovascular drug development protocol design and methodology |
| title_exact_search | Cardiovascular drug development protocol design and methodology |
| title_full | Cardiovascular drug development protocol design and methodology ed. by Jeffrey S. Borer ... |
| title_fullStr | Cardiovascular drug development protocol design and methodology ed. by Jeffrey S. Borer ... |
| title_full_unstemmed | Cardiovascular drug development protocol design and methodology ed. by Jeffrey S. Borer ... |
| title_short | Cardiovascular drug development |
| title_sort | cardiovascular drug development protocol design and methodology |
| title_sub | protocol design and methodology |
| topic | Cardiovascular Agents Congresses Cardiovascular agents Research Methodology Congresses Clinical Trials as Topic Congresses Drug Approval Congresses Kreislaufmittel (DE-588)4163325-8 gnd Arzneimittelentwicklung (DE-588)4143176-5 gnd |
| topic_facet | Cardiovascular Agents Congresses Cardiovascular agents Research Methodology Congresses Clinical Trials as Topic Congresses Drug Approval Congresses Kreislaufmittel Arzneimittelentwicklung Konferenzschrift 1996 Washington DC |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008342771&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV004737761 |
| work_keys_str_mv | AT borerjeffreys cardiovasculardrugdevelopmentprotocoldesignandmethodology |